Maternal and Child Health Journal

, Volume 19, Issue 6, pp 1173–1178 | Cite as

New Dialogue for the Way Forward in Maternal Health: Addressing Market Inefficiencies

  • Katharine McCarthy
  • Saumya Ramarao
  • Hannah Taboada


Despite notable progress in Millennium Development Goal (MDG) five, to reduce maternal deaths three-quarters by 2015, deaths due to treatable conditions during pregnancy and childbirth continue to concentrate in the developing world. Expanding access to three effective and low-cost maternal health drugs can reduce preventable maternal deaths, if available to all women. However, current failures in markets for maternal health drugs limit access to lifesaving medicines among those most in need. In effort to stimulate renewed action planning in the post-MDG era, we present three case examples from other global health initiatives to illustrate how market shaping strategies can scale-up access to essential maternal health drugs. Such strategies include: sharing intelligence among suppliers and users to better approximate and address unmet need for maternal health drugs, introducing innovative financial strategies to catalyze otherwise unattractive markets for drug manufacturers, and employing market segmentation to create a viable and sustainable market. By building on lessons learned from other market shaping interventions and capitalizing on opportunities for renewed action planning and partnership, the maternal health field can utilize market dynamics to better ensure sustainable and equitable distribution of essential maternal health drugs to all women, including the most marginalized.


Maternal health Market shaping Total market approach Lifesaving medicines Barriers to access Market segmenting 


  1. 1.
    Lozano, R., Wang, H., Foreman, K. J., et al. (2011). Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: An updated systematic analysis. Lancet, 378, 1139–1165.CrossRefPubMedGoogle Scholar
  2. 2.
    United Nations Foundation. (2012). UN commission on life-saving commodities for women and children. Commissioner’s report. Every Woman Every Child,
  3. 3.
    Wilson, R., Kade, K., Weaver, A., De Lorenzi, A., Yeager, B., Patel, S., et al. (2012). Key data and findings: Medicines for maternal health. Prepared for the United Nations commission on life-saving commodities for women and children. PATH; United Nations Population Fund (UNFPA); US Agency for International Development (USAID).Google Scholar
  4. 4.
    Dalberg Global Development Advisors. (2014). Market shaping for family planning. Brussels, Belgium: Reproductive Health Supplies Commission.Google Scholar
  5. 5.
    Matthias, D. M., Taylor, C. H., Sen, D., & Metzler, M. (2014). Local markets for global health technologies: Lessons learned from advancing 6 new products. Global Health: Science and Practice, 2(2), 152–164.Google Scholar
  6. 6.
    Barnes, J., Vail, J., & Crosby, D. (2012). Total market initiatives for reproductive health. Bethesda, MD: Abt Associates.Google Scholar
  7. 7.
    McBride, J. (2011). Total market approach to family planning in Cambodia: A case study. Washington, DC: Population Services International (PSI).Google Scholar
  8. 8.
    Bill & Melinda Gates Foundation Press Room. (2013). Innovation partnership reduces cost of Bayer’s long-acting reversible contraceptive implant by more than 50 %. Office of the Press Room.
  9. 9.
    UNITAID. (2011). Pediatric HIV/AIDS project.
  10. 10.
    Pathfinder International. (2013). New public–private partnership will halve the cost of long-lasting contraceptive implant for world’s poorest.
  11. 11.
    Merck/MSD. (2013). MSD and partners announce agreement to increase access to innovative contraceptive implants Implanon® and Implanon NXT® in the poorest countries. [Press Release].
  12. 12.
    Fisk, N. M., & Atun, R. (2008). Market failure and the poverty of new drugs in maternal health. PLOS Medicine, 5(2), 22–28.CrossRefGoogle Scholar
  13. 13.
    Population Reference Bureau. World population of women ages 15–49, projected for 2015.
  14. 14.
    Population Reference Bureau. (2013). World population data sheet, 2013.
  15. 15.
  16. 16.
    Latko, B., Temporão, J. G., Frenk, J., et al. (2011). The growing movement for universal health coverage. Lancet, 377(9784), 2161–2163.CrossRefPubMedGoogle Scholar
  17. 17.
    Chan, M. (2013). Opening remarks at a WHO/World Bank ministerial-level meeting on universal health coverage. Geneva: World Health Organization.
  18. 18.
    Bill & Melinda Gates Foundation, Office DP. (2012). Landmark summit puts women at heart of global health agenda [Press Release]. Seattle, WA: Bill & Melinda Gates Foundation and DFID.Google Scholar
  19. 19.
    USAID DELIVER. (2012). Task order 5: Procurement and distribution of essential public health supplies. Annual report FY2012, October 2011–September 2012. Arlington, VA: USAID DELIVER PROJECT.Google Scholar
  20. 20.
    Partnership for Maternal, Newborn and Child Health (PMNCH). (2013). Analyzing progress on commitments to the global strategy for women’s and children’s health. Geneva: World Health Organization.Google Scholar
  21. 21.
    Engender Health. (2007). Balancing the scales: Expanding treatment for pregnant women with life-threatening hypertensive conditions in developing countries.
  22. 22.
    UNFPA. (2011). State of worlds midwifery 2011: Delivering health, saving lives (p. 2011). New York: UNFPA.Google Scholar
  23. 23.
    Hall, P., Vemer, H. (2014). Quality of misoprostol products. Addis Ababa, Ethiopia: Workshop on Scaling Up Action to Achieve MDG-5.Google Scholar
  24. 24.
    Rational Pharmaceutical Management (RPM) Plus Program. (2008). Active management of the third stage of labor in health care facilities: Results of a national study in Ghana, 2007. Arlington, VA: Management Sciences for Health.Google Scholar
  25. 25.
    Houweling, T. A., Ronsmans, C., Campbell, O. M., & Kunst, A. E. (2007). Huge poor-rich inequalities in maternity care: An international comparative study of maternity and child care in developing countries. Bulletin of the World Health Organization, 85(10), 745–754.CrossRefPubMedCentralPubMedGoogle Scholar
  26. 26.
    Fujioka, A., Smith, J. (2011). Prevention and management of postpartum hemorrhage and pre-eclampsia/eclampsia: National programs in selected USAID program-supported countries. Maternal and Child Health Integrated Program (MCHIP),
  27. 27.
    WHO. (2012). WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva, Switzerland: World Health Organization.Google Scholar
  28. 28.
    Hatt, L., Nguyen, H., Sloan, S., et al. (2010). Economic evaluation of demand-side financing (DSF) for maternal health in Bangladesh. Bethesda, MD: Abt. Associates Inc.Google Scholar
  29. 29.
    Ahmed, S., & Khan, M. M. (2011). Is demand-side financing equity enhancing? Lessons from a maternal health voucher scheme in Bangladesh. Social Science and Medicine, 72, 1704–1710.CrossRefPubMedGoogle Scholar
  30. 30.
    Murray, C. L. J., Anderson, B., Burstein, R., et al. (2011). Development assistance for health: Trends and prospects. Lancet, 378, 8–10.CrossRefPubMedGoogle Scholar
  31. 31.
    [Editorial]. (2014). Grand convergence: a future sustainable development goal? Lancet, 383(9913), 187–280.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Katharine McCarthy
    • 1
  • Saumya Ramarao
    • 1
  • Hannah Taboada
    • 2
  1. 1.Population CouncilNew YorkUSA
  2. 2.Department of AnthropologyNew York UniversityNew YorkUSA

Personalised recommendations